Penile carcinoma

A twenty-five-year experience

Michael J. Young, Domenic J. Reda, W Waters

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The treatment of 34 patients with carcinoma of the penis wasreviewed during a twenty-five-year period (1958-1983). There were 26 patients with Stage I disease, 7 patients with Stage II, and 1 patient with Stage III disease. Among the Stage I group, 12 patients underwent partial/total penectomy and immediate ilioinguinal lymphadenectomy; 14 patients were treated with partial/total penectomy and observation of clinically nonpalpable nodes. Within the observation period, 10 of the 26 patients died, with a mean survival time of one hundred thirty-three months (standard error = 20.4), and a median of one hundred twenty months. Both the Mantel-Cox and Breslow test statistics showed the survival distribution of these groups of patients not to be significantly different from each other. All 7 patients with Stage II penile cancer died, with a mean survival time of 10.6 months (standard error = 2.1) which is significantly different from the Stage I group and the reported survival of 30-60 percent in the literature. A plan of management for the primary lesion and the role of ilioinguinal lymphadenectomy are presented.

Original languageEnglish (US)
Pages (from-to)529-532
Number of pages4
JournalUrology
Volume38
Issue number6
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Carcinoma
Lymph Node Excision
Survival Rate
Observation
Penile Neoplasms
Survival
Penis

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Penile carcinoma : A twenty-five-year experience. / Young, Michael J.; Reda, Domenic J.; Waters, W.

In: Urology, Vol. 38, No. 6, 01.01.1991, p. 529-532.

Research output: Contribution to journalArticle

Young, Michael J. ; Reda, Domenic J. ; Waters, W. / Penile carcinoma : A twenty-five-year experience. In: Urology. 1991 ; Vol. 38, No. 6. pp. 529-532.
@article{eefd49ae983a457ab7145f3b1283c9a1,
title = "Penile carcinoma: A twenty-five-year experience",
abstract = "The treatment of 34 patients with carcinoma of the penis wasreviewed during a twenty-five-year period (1958-1983). There were 26 patients with Stage I disease, 7 patients with Stage II, and 1 patient with Stage III disease. Among the Stage I group, 12 patients underwent partial/total penectomy and immediate ilioinguinal lymphadenectomy; 14 patients were treated with partial/total penectomy and observation of clinically nonpalpable nodes. Within the observation period, 10 of the 26 patients died, with a mean survival time of one hundred thirty-three months (standard error = 20.4), and a median of one hundred twenty months. Both the Mantel-Cox and Breslow test statistics showed the survival distribution of these groups of patients not to be significantly different from each other. All 7 patients with Stage II penile cancer died, with a mean survival time of 10.6 months (standard error = 2.1) which is significantly different from the Stage I group and the reported survival of 30-60 percent in the literature. A plan of management for the primary lesion and the role of ilioinguinal lymphadenectomy are presented.",
author = "Young, {Michael J.} and Reda, {Domenic J.} and W Waters",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0090-4295(91)80171-3",
language = "English (US)",
volume = "38",
pages = "529--532",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Penile carcinoma

T2 - A twenty-five-year experience

AU - Young, Michael J.

AU - Reda, Domenic J.

AU - Waters, W

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The treatment of 34 patients with carcinoma of the penis wasreviewed during a twenty-five-year period (1958-1983). There were 26 patients with Stage I disease, 7 patients with Stage II, and 1 patient with Stage III disease. Among the Stage I group, 12 patients underwent partial/total penectomy and immediate ilioinguinal lymphadenectomy; 14 patients were treated with partial/total penectomy and observation of clinically nonpalpable nodes. Within the observation period, 10 of the 26 patients died, with a mean survival time of one hundred thirty-three months (standard error = 20.4), and a median of one hundred twenty months. Both the Mantel-Cox and Breslow test statistics showed the survival distribution of these groups of patients not to be significantly different from each other. All 7 patients with Stage II penile cancer died, with a mean survival time of 10.6 months (standard error = 2.1) which is significantly different from the Stage I group and the reported survival of 30-60 percent in the literature. A plan of management for the primary lesion and the role of ilioinguinal lymphadenectomy are presented.

AB - The treatment of 34 patients with carcinoma of the penis wasreviewed during a twenty-five-year period (1958-1983). There were 26 patients with Stage I disease, 7 patients with Stage II, and 1 patient with Stage III disease. Among the Stage I group, 12 patients underwent partial/total penectomy and immediate ilioinguinal lymphadenectomy; 14 patients were treated with partial/total penectomy and observation of clinically nonpalpable nodes. Within the observation period, 10 of the 26 patients died, with a mean survival time of one hundred thirty-three months (standard error = 20.4), and a median of one hundred twenty months. Both the Mantel-Cox and Breslow test statistics showed the survival distribution of these groups of patients not to be significantly different from each other. All 7 patients with Stage II penile cancer died, with a mean survival time of 10.6 months (standard error = 2.1) which is significantly different from the Stage I group and the reported survival of 30-60 percent in the literature. A plan of management for the primary lesion and the role of ilioinguinal lymphadenectomy are presented.

UR - http://www.scopus.com/inward/record.url?scp=0025724924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025724924&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(91)80171-3

DO - 10.1016/0090-4295(91)80171-3

M3 - Article

VL - 38

SP - 529

EP - 532

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -